Integra LifeSciences Holdings Corporation
Last updated September 27, 2026
Organization details
- Legal name
- Integra LifeSciences Holdings Corporation
- Former names
- Integra Lifesciences Corp
- Ownership
- Public
- Status
- Active
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Princeton
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- IART
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000917520
- EIN
- 51-0317849
Board of directors
-
Barbara B. Hill · DirectorSince 2023
-
Christian S. Schade · DirectorSince 2023
-
Jeffrey A. Graves · DirectorSince 2023
-
Keith Bradley · DirectorSince 2023
-
Mojdeh Poul · Director · President & CEOSince 2025
-
Raymond G. Murphy · DirectorSince 2023
-
Renee Wonlai Lo · DirectorSince 2023
-
Shaundra Clay · DirectorSince 2023
-
Stuart Essig · Director · President and CEOSince 2023
-
Witte Jan De · Director · President & CEOSince 2023
Chief executives
Stuart Essig
· President and CEO
Dates unknown
Mojdeh Poul
· President & CEO
Since January 2025
Witte Jan De
· President & CEO
Until January 2025
· Former
Director election results
Annual meeting of May 7, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
89.8%
-
93.7%
-
95.0%
-
98.4%
-
98.5%
-
99.0%
-
99.6%
Board connections
5 of this board's directors also sit on 10 other boards.
- via Jeffrey A. Graves
- via Mojdeh Poul
- via Jeffrey A. Graves
- via Stuart Essig
- via Barbara B. Hill
- via Stuart Essig
- via Stuart Essig
- via Witte Jan De
- via Mojdeh Poul
- via Mojdeh Poul
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $102,150
- 1 purchase by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 1, 2026 | Veillon-Berteloot Chantal Officer (EVP & CHRO) | Shares withheld for tax | −1,455 | $16.62 | $24,182 |
| Jul 3, 2026 | Knight Lea Daniels Officer (EVP & Chief Financial Officer) | Shares withheld for tax | −5,226 | $18.05 | $94,329 |
| Jul 1, 2026 | Mosebrook Jeffrey Officer (SVP, Fin & Princ Acct Officer) | Shares withheld for tax | −937 | $17.89 | $16,763 |
| May 9, 2026 | Keith Bradley Director | Shares withheld for tax | −882 | $13.92 | $12,277 |
| May 7, 2026 | Barbara B. Hill Director | Grant or award | +6,638 | — | — |
| May 7, 2026 | Barbara B. Hill Director | Grant or award | +17,700 | — | — |
| Mar 11, 2026 | Knight Lea Daniels Officer (EVP & Chief Financial Officer) | Shares withheld for tax | −8,089 | $9.61 | $77,735 |
| Mar 11, 2026 | Veillon-Berteloot Chantal Officer (EVP & CHRO) | Shares withheld for tax | −5,420 | $9.61 | $52,086 |
| Mar 11, 2026 | McBreen Michael J. Officer (EVP & President, CSS) | Shares withheld for tax | −7,247 | $9.61 | $69,644 |
| Mar 11, 2026 | DAVIS ROBERT T. JR. Officer (EVP & President, TT) | Shares withheld for tax | −8,487 | $9.61 | $81,560 |
| Mar 11, 2026 | Mosebrook Jeffrey Officer (SVP, Fin & Princ Acct Officer) | Shares withheld for tax | −806 | $9.61 | $7,746 |
| Mar 11, 2026 | Singh Harvinder Officer (EVP & PRESIDENT, INTERNATIONAL) | Shares withheld for tax | −861 | $9.61 | $8,274 |
| Mar 11, 2026 | Singh Harvinder Officer (EVP & PRESIDENT, INTERNATIONAL) | Option exercise | +18,922 | — | — |
| Mar 11, 2026 | Singh Harvinder Officer (EVP & PRESIDENT, INTERNATIONAL) | Shares withheld for tax | −5,190 | $9.61 | $49,876 |
| Mar 10, 2026 | Singh Harvinder Officer (EVP & PRESIDENT, INTERNATIONAL) | Option exercise | +1,216 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.